|
UNCY Unicycive Therapeutics Inc 1766140 |
| Balance Sheet |
|
Current Assets
|
$71,320,000.00 |
|
Assets
|
$72,029,000.00 |
|
Current Liabilities
|
$18,704,000.00 |
|
Liabilities
|
$18,759,000.00 |
|
Equity
|
$53,270,000.00 |
|
Shares Out
|
27855257.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-13,845,000.00 |
|
Investing Cash Flow
|
$-5,178,000.00 |
| Market Analysis |
Market Cap
|
$151,811,150.65 |
|
Price
|
$4.80 |
|
BVPS
|
1.91 |
|
PB
|
2.85 |
|
EPS
|
-0.06 |
|
PS
|
224.91 |
|
FCF
|
$-13,852,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:47 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:38 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view UNCY documents filed with the SEC.
UNCY Filings
Clear
